Clinical Trial

Evaluation of Clinical Impact of Interruption VS Maintenance of AI in Patients With Locally Advanced/ Metastatic Low Grade Endometrial Stromal Sarcoma (LGESS)

Study acronym: BFR-ESS
Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The primary objective is to compare the progression-free survival (PFS) between aromatase inhibitors interruption and aromatase inhibitors maintenance strategies in patients with a locally advanced or metastatic Low Grade Endometrial Stromal Sarcoma (LGESS).
Protocol Amendment History 7 amendments
This ClinicalTrials.gov record has been amended 7 times since 2018-08-08; most recent amendment 2026-02-13.
Status change: Suspended → Recruiting 2020-04-16
Status change: Recruiting → Suspended 2020-03-23
Status change: Not Yet Recruiting → Recruiting 2019-02-05
Trial Details
NCT Number NCT03624244
Lead Sponsor Centre Leon Berard
Conditions Low Grade Endometrial Stromal Sarcoma
Enrollment 40 participants
Start Date 2019-01-23
Primary Completion 2028-01 (estimated)
Study Completion 2031-01 (estimated)
Updated on ClinicalTrials.gov 2026-02-17